Literature DB >> 16882907

Minimum ten-year results of primary bipolar hip arthroplasty for degenerative arthritis of the hip.

Vincent D Pellegrini1, Bradley A Heiges, Brian Bixler, Erik B Lehman, Charles M Davis.   

Abstract

BACKGROUND: Bipolar hip arthroplasty has been advocated by some as an alternative to total hip arthroplasty for the treatment of degenerative arthritis of the hip. We sought to assess the results of this procedure at our institution after a minimum duration of follow-up of ten years.
METHODS: We retrospectively reviewed a consecutive series of 152 patients (173 hips) who underwent primary bipolar hemiarthroplasty for the treatment of symptomatic degenerative arthritis of the hip with a cementless femoral component between 1983 and 1987. Of the original cohort of 152 patients, ninety-two patients (104 hips) were available for clinical and radiographic review at a mean of 12.2 years postoperatively. At the time of the latest follow-up, self-administered Harris hip questionnaires were used to assess pain, mobility, activity level, and overall satisfaction with the procedure. Biplanar hip radiographs were made to evaluate bipolar shell migration, osteolysis, and femoral stem fixation.
RESULTS: At the time of the latest follow-up, nineteen patients (nineteen hips) had undergone revision to total hip arthroplasty because of mechanical failure, and three patients (three hips) were awaiting revision because of symptomatic radiographic mechanical failure. Twelve acetabular revisions were performed or scheduled for the treatment of pelvic osteolysis or protrusio acetabuli secondary to component migration. Acetabular reconstruction required bone-grafting, an oversized shell, and/or a pelvic reconstruction ring. The overall rate of mechanical failure was 21.2% (twenty-two of 104 hips), with 91% (twenty) of the twenty-two failures involving the acetabular component. Reaming of the acetabulum at the time of the index arthroplasty was associated with a 6.4-fold greater risk of revision. The rate of implant survival, with revision because of mechanical failure as the end point, was 94.2% for femoral components and 80.8% for acetabular components at a mean of 12.2 years. Of the remaining sixty-nine patients (eighty-one hips) in whom the original prosthesis was retained, seventeen patients (24.6%) rated the pain as moderate to severe. Nearly 30% of patients with an intact prosthesis required analgesics on a regular basis. Radiographs were available for fifty-eight hips (including all of the hips with moderate to severe pain) after a minimum duration of follow-up of ten years; twenty-eight of these fifty-eight hips had radiographic evidence of acetabular component migration.
CONCLUSIONS: This bipolar cup, when used for hemiarthroplasty in patients with symptomatic arthritis of the hip, was associated with unacceptably high rates of pain, migration, osteolysis, and the need for revision to total hip arthroplasty, especially when the acetabulum had been reamed. To the extent that these findings can be generalized to similar implant designs with conventional polyethylene, we do not recommend bipolar hemiarthroplasty as the primary operative treatment for degenerative arthritis of the hip.

Entities:  

Mesh:

Year:  2006        PMID: 16882907     DOI: 10.2106/JBJS.01879.pp

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  14 in total

1.  Long-term clinical results of bipolar hemiarthroplasty for osteoarthritis and rheumatoid arthritis of the hip: A retrospective study.

Authors:  Tetsutaro Abe; Nobuhiro Kaku; Tomonori Tabata; Hiroaki Tagomori; Hiroshi Tsumura
Journal:  J Orthop       Date:  2019-08-12

2.  Evaluation of bipolar hemiarthroplasty for the treatment of steroid-induced osteonecrosis of the femoral head.

Authors:  Mitsutoshi Moriya; Katsufumi Uchiyama; Naonobu Takahira; Kensuke Fukushima; Takeaki Yamamoto; Keika Hoshi; Moritoshi Itoman; Masashi Takaso
Journal:  Int Orthop       Date:  2012-07-17       Impact factor: 3.075

3.  Reasons for revision of failed hemiarthroplasty: Are there any differences between unipolar and bipolar?

Authors:  Khanin Iamthanaporn; Keerati Chareancholvanich; Chaturong Pornrattanamaneewong
Journal:  Eur J Orthop Surg Traumatol       Date:  2018-03-16

4.  How Often Do Acetabular Erosions Occur After Bipolar Hip Endoprostheses in Patients With Malignant Tumors and Are Erosions Associated With Outcomes Scores?

Authors:  Matthew T Houdek; Peter S Rose; Peter C Ferguson; Franklin H Sim; Anthony M Griffin; Mario Hevesi; Jay S Wunder
Journal:  Clin Orthop Relat Res       Date:  2019-04       Impact factor: 4.176

5.  Clinical results of hemiarthroplasty using new bipolar cups for stage 3 or lower osteonecrosis of the femoral head: a retrospective study.

Authors:  T Abe; N Kaku; T Tabata; H Tagomori; H Tsumura
Journal:  Musculoskelet Surg       Date:  2017-11-18

6.  Randomized trial of hemiarthroplasty versus internal fixation for femoral neck fractures: no differences at 6 years.

Authors:  Ragnhild Øydna Støen; Cathrine M Lofthus; Lars Nordsletten; Jan Erik Madsen; Frede Frihagen
Journal:  Clin Orthop Relat Res       Date:  2013-08-24       Impact factor: 4.176

7.  Radiographic evaluation of linear wear of bipolar hemiarthroplasty devices in vivo.

Authors:  Nobuhiro Kaku; Shouhei Noda; Tomonori Tabata; Hiroaki Tagomori; Hiroshi Tsumura
Journal:  J Clin Orthop Trauma       Date:  2018-07-20

8.  How long do endoprosthetic reconstructions for proximal femoral tumors last?

Authors:  Nicholas M Bernthal; Adam J Schwartz; Daniel A Oakes; J Michael Kabo; Jeffrey J Eckardt
Journal:  Clin Orthop Relat Res       Date:  2010-11       Impact factor: 4.176

9.  The conversion rate of bipolar hemiarthroplasty after a hip fracture to a total hip arthroplasty.

Authors:  Sulaiman Alazzawi; Walter B Sprenger De Rover; James Brown; Ben Davis
Journal:  Clin Orthop Surg       Date:  2012-05-17

10.  Conversion of failed hemiarthroplasty to total hip arthroplasty: a short to mid-term follow-up study.

Authors:  Amite Pankaj; Rajesh Malhotra; Surya Bhan
Journal:  Indian J Orthop       Date:  2008-07       Impact factor: 1.251

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.